Skip to main content
×
×
Home

Setting standards for physical health monitoring in patients on antipsychotics

  • Samantha Churchward (a1), Susan M. Oxborrow (a2), Victor O. Olotu (a3) and M. Deepak Thalitaya (a4)
Abstract
Aims and Method

To develop standards for physical health monitoring in patients on antipsychotics in a forensic environment. We reviewed recommendations for physical health checks from key publications and then agreed a consensus on what to monitor and how often.

Results

We developed a standardised form to ensure the requisite minimum monitoring is performed when a patient is newly prescribed an antipsychotic drug or the dose is increased, when an abnormality is detected and for routine annual physical health monitoring.

Clinical Implications

We have produced a pragmatic solution to the gap between the recognised risks to physical health of individuals treated with antipsychotic medication and the need for clear, unambiguous standards of physical healthcare.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Setting standards for physical health monitoring in patients on antipsychotics
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Setting standards for physical health monitoring in patients on antipsychotics
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Setting standards for physical health monitoring in patients on antipsychotics
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
1 Cohen, A, Hove, M. Physical Health of the Severe and Enduring Mentally Ill. Sainsbury Centre for Mental Health, 2001.
2 Sebastian, C, Beer, MD. Physical health of psychiatric patients admitted to a low secure challenging behaviour unit. J Psychiatr Intensive Care 2006; 1: 7783.
3 Thomson, L, Bogue, J, Humphreys, M, Owens, D, Johnstone, E. The State Hospital Survey: a description of psychiatric patients in conditions of special security in Scotland. J Forensic Psychiatr 1997; 8: 263–84.
4 Marder, SR, Essock, SM, Miller, AL, Buchanan, RW, Casey, DE, Davis, JM, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004; 161: 1334–49.
5 National Institute for Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. NICE, 2002.
6 Gough, K, Churchward, S, Dorkins, E, Fee, J, Oxborrow, S, Parker, J, et al. Audit of the NICE Guidelines for Schizophrenia in an NHS forensic psychiatric service. Br J Forensic Pract 2007; 9: 2834.
7 Singh, R, Ahmed, MJR, Shaffiullha, M. Audit of monitoring of second generation antipsychotic drugs? Bulletin of Transcultural Special Interest Group of Royal College of Psychiatrists, Autumn 2007, 10–6.
8 Zhang, Z-J, Yao, Z-J, Liu, W, Fang, Q, Reynolds, GP. Effects of antipsychotics on fat deposition and changes in leptin and Insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia. Br J Psychiatry 2004; 184: 5862.
9 McCreadie, RG. Diet, smoking and cardiovascular risk in people with schizophrenia. Descriptive study. Br J Psychiatry 2003; 183: 534–9.
10 Thakore, JH. Metabolic syndrome and schizophrenia. Br J Psychiatry 2005; 186: 455–6.
11 Haddad, PM. Antipsychotics and diabetes: review of non-prospective data. Br J Psychiatry 2004; 184 (suppl 47): s806.
12 Lambert, T, Chapman, L. Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement. Med J Aust 2004; 181: 544–8.
13 Petty, RG. Prolactin and antipsychotic medications: mechanism of action. Schizophr Res 1999; 35 (suppl 1): 6773.
14 Holt, RIG. The medical causes and consequences of hyperprolactinaemia. A context for psychiatrists. J Psychopharmacol 2008; 22 (suppl 2): 2837.
15 Berner, MM, Hagen, M, Kriston, L. Management of sexual dysfunction due to antipsychotic drug therapy? Cochrane Database Syst Rev 2007; Issue 3: CD003546.
16 Herxheimer, A, Healy, D. Arrhythmias and sudden death in patients taking antipsychotic drugs. BMJ 2002; 325: 1253–4.
17 Ray, WA, Meador, KG. Antipsychotics and sudden death: is thioridazine the only bad actor? Br J Psychiatry 2002; 180: 483–4.
18 Abdelmawla, N, Mitchell, AJ. Sudden cardiac death and antipsychotics. Part 2: Monitoring and prevention. Adv Psychiatr Treat 2006; 12: 100–9.
19 Haddad, PM, Sharma, SG. Adverse effects of atypical antipsychotics: differential risk and clinical implications. CNS Drugs 2007; 21: 911–36.
20 Gill, SS, Rochon, PA, Herrmann, N, Philip, EL, Sykora, K, Gunraj, N, et al. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ 2005; 330: 445.
21 NHS Connecting for Health. NHS Care Record Service. NHS, 2005.
22 Brennan, S. The NHS IT Project: the Biggest Computer Project in the World Ever. Radcliffe Publishing, 2005.
23 Association of the British Pharmaceutical Industry (ABPI): ABPI Medicines Compendium. Datapharm Communications, 2006 (http://www.emc.medicines.org.uk).
24 British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary 51. BMA, 2006.
25 David, T, Paton, C, Kerwin, R. The Maudsley 2005–2006 Prescribing Guidelines (8th edn). Taylor and Francis, 2005.
26 Lebovitz, HE. Metabolic consequences of atypical antipsychotic drugs. Psychiatr Q 2003; 74: 277–90.
27 Antai-Otong, D. Metabolic effects associated with atypical antipsychotic medications. Perspect Psychiatr Care 2004; 40: 70–2.
28 American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004: 27: 596601.
29 Medicines Control Agency, Committee on Safety of Medicines. QT interval prolongation with antipsychotics. Curr Probl Pharmacovigilance 2001; 27: 4.
30 Royal College of Psychiatrists. Consensus Statement on High-Dose Antipsychotic Medication (CR138). Royal College of Psychiatrists, 2006.
31 Maguire, GA. Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences. J Clin Psychiatry 2002; 63 (suppl 4): 5662.
32 Day, JC, Wood, G, Dewey, M, Bentall, RP. A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br J Psychiatry 1995; 166: 650–3.
33 Rowlands, P. The NICE schizophrenia guidelines: the challenge of implementation. Adv Psychiatr Treat 2004; 10: 403–12.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×
Type Description Title
PDF
Supplementary materials

Churchward et al. supplementary material
Supplementary Material

 PDF (24 KB)
24 KB
UNKNOWN
Supplementary materials

Churchward et al. supplementary material
Supplementary Material

 Unknown (450 bytes)
450 bytes

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 13 *
Loading metrics...

Abstract views

Total abstract views: 65 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 20th July 2018. This data will be updated every 24 hours.

Setting standards for physical health monitoring in patients on antipsychotics

  • Samantha Churchward (a1), Susan M. Oxborrow (a2), Victor O. Olotu (a3) and M. Deepak Thalitaya (a4)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *